Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-25

FDA Approved: PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic pioglitazone hydrochloride and metformin hydrochloride combination product intended for type 2 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pioglitazone hydrochloride and metformin hydrochloride (Pioglitazone hydrochloride and metformin hydrochloride)

Snippet

SUPPL AP for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE)